Skip Navigation


IJE Advance Access originally published online on July 26, 2007
International Journal of Epidemiology 2007 36(4):713-717; doi:10.1093/ije/dym152
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/4/713    most recent
dym152v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Pearce, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pearce, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2007; all rights reserved.

Commentary: The rise and rise of corporate epidemiology and the narrowing of epidemiology's vision

Neil Pearce

Centre for Public Health Research, Massey University Wellington Campus, Private Box 756, Wellington, New Zealand.

E-mail: n.e.pearce@massey.ac.nz

Accepted 7 February 2007

The first 150 words of the full text of this article appear below.

Reports of the impending death of epidemiology1 have proven premature. The year 2000 dawned, and our computer systems, and our system of epidemiological research, both continued to function. When judged by the numbers of epidemiology journals, publications and academic positions, the field is clearly thriving.

Nevertheless, to have survived is not necessarily enough, and more is not necessarily better. The Rolling Stones have also survived since the 1960s, and sell more albums and concert tickets than ever, even though their ages passed their IQs in the 1990s and Keith Richards was lost to follow-up back in about 1975. When the current state of epidemiology is assessed in terms of quality rather than quantity, it is arguable that Ken Rothman's pessimistic vision of decline1 has partly been realized. The ‘golden age’ of risk factor epidemiology seems to have passed. The major discoveries (e.g. tobacco smoking and lung cancer, asbestos and lung . . . [Full Text of this Article]


   The scope and vision of epidemiology
 

   Corporate epidemiology
 

   Conclusions
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Int J EpidemiolHome page
N. Pearce
Response: The distribution and determinants of epidemiologic research
Int. J. Epidemiol., February 1, 2008; 37(1): 65 - 68.
[Full Text] [PDF]

Home page
 Int J EpidemiolHome page
N. Pearce
Corporate influences on epidemiology
Int. J. Epidemiol., February 1, 2008; 37(1): 46 - 53.
[Abstract] [Full Text] [PDF]